ACETAMINOPHEN, ASPIRIN AND CAFFEINE

Post-LOE

acetaminophen, aspirin, caffeine

ANDAORALTABLET
Approved
Nov 2001
Lifecycle
Post-LOE
Competitive Pressure
30/100
Clinical Trials
1

Mechanism of Action

Cyclooxygenase Inhibitors

Pharmacologic Class:

Nonsteroidal Anti-inflammatory Drug

Indications (1)

Clinical Trials (1)

NCT01248468Phase 4Completed

Efficacy and Safety of Acetaminophen, Aspirin and Caffeine With Sumatriptan in the Acute Treatment of Migraine

Started Nov 2010
752 enrolled
Pain, Migraine